Granulox Haemoglobin Based Spray - Case of 6

Granulox is an innovative haemoglobin-based oxygenating spray designed to accelerate healing in chronic and hard-to-heal wounds. When sprayed onto the wound surface, it releases highly purified haemoglobin that captures oxygen from the surrounding air and transports it through the wound exudate directly to the wound bed. This targeted oxygenation addresses the hypoxic conditions that stall healing in chronic wounds, supporting faster tissue repair and improved patient outcomes. The portable spray format integrates easily into existing wound care routines and should be applied at each dressing change, at least every three days. Supplied as a case of 6 canisters.

Key Features

• Haemoglobin-Based Oxygenation: Delivers purified haemoglobin to the wound bed, capturing atmospheric oxygen and transporting it directly to hypoxic tissue
• Clinically Proven Results: Studies show double the number of chronic wounds healed within 8 to 16 weeks compared to standard care alone
• Faster Diabetic Foot Ulcer Healing: Healing time for diabetic foot ulcers reduced by 50% compared to conventional treatment
• Pain Reduction: Over 70% of patients reported lower average pain levels after four weeks of use
• Slough Reduction: 99% reduction in wound slough after 4 weeks compared to 33% with standard care
• Cost Effective: Treatment costs for diabetic foot ulcers reduced by at least 40% compared to traditional care methods

Applications

Granulox is used across NHS tissue viability clinics, diabetic foot services and community wound care teams for managing chronic wounds including diabetic foot ulcers, venous leg ulcers, arterial and mixed leg ulcers, pressure sores and secondary healing surgical wounds. It is also effective on sloughy and infected wounds where oxygen deprivation at the wound bed is a barrier to healing progression.